Welcome to our dedicated page for Real Brands news (Ticker: RLBD), a resource for investors and traders seeking the latest updates and insights on Real Brands stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Real Brands's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Real Brands's position in the market.
Real Brands Inc. (RLBD) has added Dr. Richard Goldberg to its Board of Directors and engaged him in a consulting agreement for guidance in their new Psychedelics research division. Dr. Goldberg, a renowned expert in Psychiatry, will contribute to the development of psychedelic drug therapies. The move marks a significant step in establishing a relationship with a certified medical research facility necessary for securing a psychedelic drug research license from the DEA. The partnership aims to explore the potential of psychedelic therapies in treating psychiatric conditions, leveraging Dr. Goldberg's extensive experience and expertise.
Real Brands Inc. (OTCPK: RLBD) has signed a letter of intent to acquire Vapor Shark assets, a pioneer in online B2B and B2C business with robust sales channels. The acquisition will provide new distribution channels, enabling Real Brands to tap into the $29.3 billion tobacco and hemp vapor market by 2029.
Real Brands Inc. (OTCQB: RLBD) has announced the acquisition of Boulder Botanical & Biosciences Laboratories, a leader in white-label herbal supplements and CBD products, for $12 million. This deal boosts Real Brands' production capacity by 300% and adds over 150 brands to its portfolio. Boulder Botanical, known for its expertise in sports medicine and wellness products, will enhance Real Brands' market reach, distributing through major retailers like CVS and Target. The acquisition aims to capture growth in the $2.6 billion U.S. herbal supplements market, projected to grow at 10.62% CAGR through 2027.
Real Brands Inc. (OTCQB: RLBD) has signed a letter of intent to acquire Boulder Botanicals & Biosciences Laboratories, enhancing its portfolio in the CBD sector. The transaction involves Boulder Botanical's brands, IP, and a 27,000 sq. ft. production facility in Golden, Colorado. This acquisition offers Real Brands access to 150 proprietary formulations and established distribution networks, aiming to capture a larger share of the predicted $47.2 billion CBD market by 2028. The deal is pending a definitive agreement and due diligence, with formal closing expected shortly.
Real Brands (OTCQB: RLBD) is expanding into the medical psychedelics market by applying for DEA licensure to produce and handle psychedelics. Their initiative aims to develop safe, nature-based products for treating mental health conditions, addressing the ineffectiveness of traditional therapies. This move comes as the psychedelics market is projected to grow to $10.75 billion by 2027. The company has partnered with Marcu & Arora to navigate the regulatory landscape and intends to explore micro-dosing and various psychedelics like psilocybin and mescaline for therapeutic use.
Real Brands (OTCQB:RLBD) CEO Thom Kidrin discussed significant company developments in an interview with Capital Gains Report. Key points include anticipation of revenue guidance in Q2 or Q3 2022, ongoing discussions for acquisitions in the CBD beverage sector, and the company's strategic partnership with Turning Point Brands (TPB), which holds a 23% equity stake. Kidrin highlighted an international distribution deal and the firm’s efforts to integrate celebrity marketing. The company also aims to innovate with unique formulations targeting health issues.
Real Brands (OTCQB: RLBD) has announced a strategic distribution partnership with Karanten Ltd. in Budapest, marking its first venture into the EU market. The collaboration will initially focus on launching Real Brands' WA line of CBD-infused cosmetics and topicals, available through www.warazslat.hu. This partnership aims to enhance profit margins and increase shareholder value as the EU market for hemp-derived CBD products expands.
Real Brands Inc. (OTCPK: RLBD) has received approval to uplist from the OTC Pink market to the OTCQB, effective March 2, 2022. This change is viewed as a major milestone, enhancing transparency and attracting higher-quality investors. The company aims to leverage this uplisting to accelerate its growth strategy in developing new CBD products and expanding its brand lines. Real Brands focuses on the extraction and wholesale of CBD products, while committing resources to proprietary brands and novel formulations.
Real Brands Inc. (OTCPK: RLBD) has submitted its application to the OTC Markets Group to uplist from the OTC Pink market to the OTCQB, acknowledging extensive documentation and audit requirements. CEO Thom Kidrin highlighted delays caused by COVID-19 in their uplisting process. The company fulfills OTCQB criteria, including filing Form 10 and maintaining audited financials. Real Brands aims to enhance its brand portfolio in hemp-derived products, including cosmetics and edibles. Uplisting is expected to improve funding opportunities and attract a more discerning investor base.
Real Brands Inc. (OTCPK: RLBD) has announced the launch of its new PHAZE brand, a hemp extract-based sports wellness line tailored for athletes. The product range targets specific daily activities: Rise, Compete, Recover, and Sleep, utilizing high-quality, organic ingredients sourced from U.S. hemp. PHAZE offers eight initial products, including topical creams, gum, tinctures, and patches, with plans to expand to approximately 20 SKUs by the end of 2022. The direct-to-consumer e-commerce site PhazeSports.com is now live.